NDMA Suggests Changes To Proposed Disease Definition
This article was originally published in The Tan Sheet
Executive Summary
The Nonprescription Drug Manufacturers Association, in Sept. 24 comments on FDA's proposed structure/function claims rules, suggests FDA modify its definition of "disease" to more closely fit within the scope of the Dietary Supplement Health & Education Act. "FDA's proposed definition of disease is overly expansive, by referencing 'any deviation from...normal structure or function,'" NDMA says.